Microbot Medical Inc (MBOT) concluded trading on Thursday at a closing price of $2.74, with 4.73 million shares of worth about $12.97 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 37.69% during that period and on July 24, 2025 the price saw a loss of about -3.52%. Currently the company’s common shares owned by public are about 36.38M shares, out of which, 35.98M shares are available for trading.
Stock saw a price change of 8.73% in past 5 days and over the past one month there was a price change of 11.38%. Year-to-date (YTD), MBOT shares are showing a performance of 158.49% which increased to 144.64% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.82 but also hit the highest price of $3.38 during that period. The average intraday trading volume for Microbot Medical Inc shares is 1.62 million. The stock is currently trading 7.55% above its 20-day simple moving average (SMA20), while that difference is up 6.94% for SMA50 and it goes to 53.17% higher than SMA200.
Microbot Medical Inc (NASDAQ: MBOT) currently have 36.38M outstanding shares and institutions hold larger chunk of about 11.17% of that.
The stock has a current market capitalization of $99.67M and its 3Y-monthly beta is at 1.17. It has posted earnings per share of -$0.64 in the same period. It has Quick Ratio of 16.19 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MBOT, volatility over the week remained 9.90% while standing at 6.42% over the month.
Stock’s fiscal year EPS is expected to rise by 56.16% while it is estimated to increase by 28.12% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by H.C. Wainwright on January 13, 2020 offering a Buy rating for the stock and assigned a target price range of between $12 and $26 to it. Coverage by H.C. Wainwright stated Microbot Medical Inc (MBOT) stock as a Buy in their note to investors on December 24, 2019, suggesting a price target of $12 for the stock.
